Cargando…

Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe

PURPOSE: Although first-episode psychosis (FEP) in youth, particularly early-onset schizophrenia (EOS), is managed similarly to adult-onset schizophrenia, few antipsychotics are approved for people aged 13–18 years. We aimed to explore areas of uncertainty in EOS management and provide evidence-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correll, Christoph U, Fusar-Poli, Paolo, Leucht, Stefan, Karow, Anne, Maric, Nadja, Moreno, Carmen, Nordentoft, Merete, Raballo, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843859/ https://www.ncbi.nlm.nih.gov/pubmed/35177905 http://dx.doi.org/10.2147/NDT.S345066

Ejemplares similares

Patterns of Care for Adolescent With Schizophrenia: A Delphi-Based Consensus Study
por: Vita, Antonio, et al.
Publicado: (2022)

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery
por: Arango, Celso, et al.
Publicado: (2023)

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery
por: Arango, Celso, et al.
Publicado: (2023)

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
por: Galderisi, Silvana, et al.
Publicado: (2021)

Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later
por: Lambert, Martin, et al.
Publicado: (2010)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
por: Taipale, Heidi, et al.
Publicado: (2022)

T175. THE GUT-MICROBIOTA AS A TARGET FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED TRIALS OF ADD-ON STRATEGIES
por: Minichino, Amedeo, et al.
Publicado: (2020)

Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review
por: Vulto, Arnold G., et al.
Publicado: (2020)

Palliative care competencies for geriatricians across Europe: a Delphi consensus study
por: Pautex, Sophie, et al.
Publicado: (2021)

Developing consensus-based policy solutions for medicines adherence for Europe: a delphi study
por: Clyne, Wendy, et al.
Publicado: (2012)

O11.2. CHANGES IN PSYCHOPATHOLOGY PREDICT CHANGES IN WORKING ALLIANCE IN FIRST EPISODE PSYCHOSIS
por: Melau, Marianne, et al.
Publicado: (2018)

Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis
por: Correll, Christoph U, et al.
Publicado: (2023)

Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010)

Clinical outcomes in brief psychotic episodes: a systematic review and meta-analysis
por: Provenzani, U., et al.
Publicado: (2021)

Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Clinical predictors of therapeutic response to antipsychotics in schizophrenia
por: Carbon, Maren, et al.
Publicado: (2014)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

O4.2. THE PREVENTION OF RELAPSE AND HOSPITALIZATION IN FIRST EPISODE AND EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE PRELAPSE TRIAL
por: Kane, John, et al.
Publicado: (2020)

The Danish Schizophrenia Registry
por: Baandrup, Lone, et al.
Publicado: (2016)

ITAlian partnership for psychosis prevention (ITAPP): Improving the mental health of young people
por: Fusar-Poli, Paolo, et al.
Publicado: (2021)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic, Martha, et al.
Publicado: (2018)

Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders
por: Rodolico, Alessandro, et al.
Publicado: (2022)

T83. SUBSTANCE-INDUCED PSYCHOSIS LINKED TO BOTH INFECTIONS AND SCHIZOPHRENIA
por: Hjorthøj, Carsten, et al.
Publicado: (2020)

Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR
por: Stürup, Anne Emilie, et al.
Publicado: (2022)

Non-pharmacological treatments for schizophrenia in Southeast Europe: An expert survey
por: Stevović, Lidija Injac, et al.
Publicado: (2021)

O9.1. CANNABIS AND OTHER SUBSTANCE USE DISORDERS PREDICT CONVERSION FROM SCHIZOTYPAL DISORDER TO SCHIZOPHRENIA
por: Hjorthoj, Carsten, et al.
Publicado: (2018)

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
por: Meyer, Jonathan M., et al.
Publicado: (2023)

Essentials for Standardising the Undergraduate Urology Curriculum in Europe: Outcomes of a Delphi Consensus from the European School of Urology
por: Gómez Rivas, Juan, et al.
Publicado: (2021)

Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study
por: Llorca, Pierre-Michel, et al.
Publicado: (2022)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
por: Correll, Christoph U, et al.
Publicado: (2020)

Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Findings from the EUGEI study
por: Fusar-Poli, L., et al.
Publicado: (2023)

New Developments in the Treatment of Schizophrenia: An Expert Roundtable
por: Kantrowitz, Joshua T, et al.
Publicado: (2023)

Early detection of bipolar disorders and treatment recommendations for help-seeking adolescents and young adults: Findings of the Early Detection and Intervention Center Dresden
por: Martini, Julia, et al.
Publicado: (2021)

Before Schizophrenia: Schizophrenic Vulnerability in Developmental Age and Its Detection
por: Poletti, Michele, et al.
Publicado: (2021)

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives
por: Correll, Christoph U., et al.
Publicado: (2011)

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists
por: Correll, Christoph U, et al.
Publicado: (2019)

S126. GOOD OUTCOME IN INDIVIDUALS AT ULTRA-HIGH RISK (UHR) OF DEVELOPING PSYCHOSIS: A DELPHI STUDY
por: Petros, Natalia, et al.
Publicado: (2018)

Consensus Definition of Misophonia: A Delphi Study
por: Swedo, Susan E., et al.
Publicado: (2022)

Developing consensus in Histopathology: the role of the Delphi method
por: Taze, Dilek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_am3hoo0cej755a6n3vgmqsa59t